Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Toll-like receptor signaling pathway	7/104	1.685683517457845e-12	1.41597415466459e-10	287.64948453608247	-468.5892523422357	MYD88;NFKB1;TLR2;TLR3;TLR4;TLR5;TRAF6
KEGG_2021_Human	Legionellosis	5/57	1.8035789800331409e-09	7.575031716139192e-08	192.71634615384616	-394.9283087964063	MYD88;NFKB1;TLR2;TLR4;TLR5
KEGG_2021_Human	Hepatitis B	6/162	4.7415420745907735e-09	1.3276317808854167e-07	101.44871794871794	-265.06511429557594	MYD88;NFKB1;TLR2;TLR3;TLR4;TRAF6
KEGG_2021_Human	Leishmaniasis	5/77	8.440186820577363e-09	1.7724392323212465e-07	138.83680555555554	-313.3605831956858	MYD88;NFKB1;TLR2;TLR4;TRAF6
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	5/89	1.7643026292910263e-08	2.9640284172089245e-07	118.82440476190476	-279.4467870401097	MYD88;NFKB1;TLR2;TLR4;TRAF6
KEGG_2021_Human	Chagas disease	5/102	3.5212348911930974e-08	4.929728847670336e-07	102.73195876288659	-250.4281900950136	MYD88;NFKB1;TLR2;TLR4;TRAF6
KEGG_2021_Human	Coronavirus disease	6/232	4.1138788997474926e-08	4.936654679696991e-07	69.40707964601769	-194.941690315207	MYD88;NFKB1;TLR2;TLR3;TLR4;TRAF6
KEGG_2021_Human	Toxoplasmosis	5/112	5.647876947957307e-08	5.862645860690626e-07	93.01401869158879	-232.0370038112063	MYD88;NFKB1;TLR2;TLR4;TRAF6
KEGG_2021_Human	Salmonella infection	6/249	6.281406279311384e-08	5.862645860690626e-07	64.41152263374485	-183.0882748425103	MYD88;NFKB1;TLR2;TLR4;TLR5;TRAF6
KEGG_2021_Human	Measles	5/139	1.6737492207318742e-07	1.4059493454147744e-06	74.0205223880597	-193.86778912663115	MYD88;NFKB1;TLR2;TLR4;TRAF6
KEGG_2021_Human	Inflammatory bowel disease	4/65	4.668129760639229e-07	3.5647536353972294e-06	105.02295081967213	-213.71770630232584	NFKB1;TLR2;TLR4;TLR5
KEGG_2021_Human	Tuberculosis	5/180	6.092181617292973e-07	4.264527132105081e-06	56.385714285714286	-155.18960463560154	MYD88;NFKB1;TLR2;TLR4;TRAF6
KEGG_2021_Human	Pertussis	4/76	8.797646849986461e-07	5.68463334922202e-06	88.85555555555555	-188.59549699748743	MYD88;NFKB1;TLR4;TRAF6
KEGG_2021_Human	Pathogenic Escherichia coli infection	5/197	9.544535251892481e-07	5.726721151135489e-06	51.282552083333336	-143.27660157703332	MYD88;NFKB1;TLR4;TLR5;TRAF6
KEGG_2021_Human	Human immunodeficiency virus 1 infection	5/212	1.37386592166496e-06	7.693649161323777e-06	47.47584541062802	-134.14359666851644	MYD88;NFKB1;TLR2;TLR4;TRAF6
KEGG_2021_Human	Lipid and atherosclerosis	5/215	1.4729854454229273e-06	7.733173588470369e-06	46.779761904761905	-132.449281449783	MYD88;NFKB1;TLR2;TLR4;TRAF6
KEGG_2021_Human	Shigellosis	5/246	2.86800965527578e-06	1.417134182606856e-05	40.601659751037346	-117.05617955492606	MYD88;NFKB1;TLR4;TLR5;TRAF6
KEGG_2021_Human	NF-kappa B signaling pathway	4/104	3.1092852811986736e-06	1.4509997978927145e-05	63.752	-145.71127254838157	MYD88;NFKB1;TLR4;TRAF6
KEGG_2021_Human	Yersinia infection	4/137	9.341058998242965e-06	4.1297313465916264e-05	47.73533834586466	-115.08325950004442	MYD88;NFKB1;TLR4;TRAF6
KEGG_2021_Human	Malaria	3/50	1.8261732810105806e-05	7.66992778024444e-05	85.34042553191489	-136.59746786994486	MYD88;TLR2;TLR4
KEGG_2021_Human	Influenza A	4/172	2.3010807243183006e-05	9.204322897273202e-05	37.62380952380953	-93.9608075055161	MYD88;NFKB1;TLR3;TLR4
KEGG_2021_Human	NOD-like receptor signaling pathway	4/181	2.8140456110956267e-05	0.00010744537787819665	35.67005649717514	-89.68342157258434	MYD88;NFKB1;TLR4;TRAF6
KEGG_2021_Human	Neutrophil extracellular trap formation	4/189	3.3368265712771674e-05	0.00012186670955968784	34.09297297297297	-86.1786838942694	HDAC6;NFKB1;TLR2;TLR4
KEGG_2021_Human	Epstein-Barr virus infection	4/202	4.3345860214068684e-05	0.0001517105107492404	31.802020202020202	-81.00014600980846	MYD88;NFKB1;TLR2;TRAF6
KEGG_2021_Human	Herpes simplex virus 1 infection	5/498	8.938323856667933e-05	0.00030032768158404254	19.20892494929006	-57.46081956672664	MYD88;NFKB1;TLR2;TLR3;TRAF6
KEGG_2021_Human	Amoebiasis	3/102	0.0001553857406236281	0.0005020154697071061	40.25252525252525	-75.60230978738817	NFKB1;TLR2;TLR4
KEGG_2021_Human	Hepatitis C	3/157	0.000555171423312075	0.0017271999836375666	25.698051948051948	-51.16015712271987	NFKB1;TLR3;TRAF6
KEGG_2021_Human	RIG-I-like receptor signaling pathway	2/70	0.00256220797992988	0.007686623939789639	33.61764705882353	-41.26579239949642	NFKB1;TRAF6
KEGG_2021_Human	MAPK signaling pathway	3/294	0.003404470153914145	0.009861223894096145	13.36426116838488	-27.04477578435615	MYD88;NFKB1;TRAF6
KEGG_2021_Human	Small cell lung cancer	2/92	0.004384956936205731	0.012005307255128814	25.33015873015873	-32.38073681020333	NFKB1;TRAF6
KEGG_2021_Human	IL-17 signaling pathway	2/94	0.004573450382906214	0.012005307255128814	24.773291925465838	-31.752738777128943	NFKB1;TRAF6
KEGG_2021_Human	Rheumatoid arthritis	2/93	0.004478735545212194	0.012005307255128814	25.04866562009419	-32.063828626815045	TLR2;TLR4
KEGG_2021_Human	PI3K-Akt signaling pathway	3/354	0.005753886468725447	0.014646256465846592	10.994301994301994	-21.89541652967131	NFKB1;TLR2;TLR4
KEGG_2021_Human	HIF-1 signaling pathway	2/109	0.006105352720275968	0.015083812603034744	21.26034712950601	-27.68582717074483	NFKB1;TLR4
KEGG_2021_Human	Neurotrophin signaling pathway	2/119	0.007240587298154556	0.017377409515570933	19.418803418803417	-25.474864071873153	NFKB1;TRAF6
KEGG_2021_Human	Osteoclast differentiation	2/127	0.008213083210946173	0.01916386082554107	18.157714285714285	-23.926174303508194	NFKB1;TRAF6
KEGG_2021_Human	Phagosome	2/152	0.011610754847249553	0.026359551545107093	15.083809523809524	-20.020850313494247	TLR2;TLR4
KEGG_2021_Human	Necroptosis	2/159	0.012657031916689763	0.027978702131630003	14.398544131028208	-19.122798529767856	TLR3;TLR4
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	2/193	0.018305168945798957	0.039426517729413135	11.784592370979805	-15.594506527477616	NFKB1;TLR3
KEGG_2021_Human	Proteoglycans in cancer	2/205	0.02051521426008122	0.042031170679190794	11.071076706544687	-14.601094649812358	TLR2;TLR4
KEGG_2021_Human	Viral carcinogenesis	2/203	0.020139252108142023	0.042031170679190794	11.18407960199005	-14.75934041894059	HDAC6;NFKB1
KEGG_2021_Human	African trypanosomiasis	1/37	0.04049551865831964	0.08099103731663929	27.89236111111111	-15.184460455315875	MYD88
KEGG_2021_Human	Human papillomavirus infection	2/331	0.0498033032771934	0.09729017384381967	6.721667390360399	-8.231969519638584	NFKB1;TLR3
KEGG_2021_Human	Cocaine addiction	1/49	0.053312458983950796	0.10177833078754242	20.888020833333332	-11.903933011994981	NFKB1
KEGG_2021_Human	Cytosolic DNA-sensing pathway	1/63	0.06807303774497875	0.12706967045729367	16.143145161290324	-9.472518280745922	NFKB1
KEGG_2021_Human	Prolactin signaling pathway	1/70	0.07537632257699178	0.12921655298912876	14.492753623188406	-8.576836282024367	NFKB1
KEGG_2021_Human	Epithelial cell signaling in Helicobacter pylori infection	1/70	0.07537632257699178	0.12921655298912876	14.492753623188406	-8.576836282024367	NFKB1
KEGG_2021_Human	Acute myeloid leukemia	1/67	0.07225259654096947	0.12921655298912876	15.157196969696969	-8.940904692220872	NFKB1
KEGG_2021_Human	Adipocytokine signaling pathway	1/69	0.07433612093989085	0.12921655298912876	14.707720588235293	-8.695150624681633	NFKB1
KEGG_2021_Human	Pancreatic cancer	1/76	0.08159574176033811	0.1343929864287922	13.323333333333334	-7.924002328332589	NFKB1
KEGG_2021_Human	Chronic myeloid leukemia	1/76	0.08159574176033811	0.1343929864287922	13.323333333333334	-7.924002328332589	NFKB1
KEGG_2021_Human	B cell receptor signaling pathway	1/81	0.08675015538899065	0.14013486639760028	12.4828125	-7.444675790846853	NFKB1
KEGG_2021_Human	Th1 and Th2 cell differentiation	1/92	0.09799945337690771	0.15531988837094807	10.958791208791208	-6.552151761424751	NFKB1
KEGG_2021_Human	T cell receptor signaling pathway	1/104	0.1101307870056494	0.1572898688608827	9.66747572815534	-5.770076289156004	NFKB1
KEGG_2021_Human	Prostate cancer	1/97	0.1030719256198476	0.1572898688608827	10.381510416666666	-6.205609665169881	NFKB1
KEGG_2021_Human	Th17 cell differentiation	1/107	0.11314086575838443	0.1572898688608827	9.390330188679245	-5.598891001043246	NFKB1
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	1/100	0.10610322337144797	0.1572898688608827	10.063131313131313	-6.012374432750834	NFKB1
KEGG_2021_Human	Longevity regulating pathway	1/102	0.10811902604280113	0.1572898688608827	9.861386138613861	-5.889129551383326	NFKB1
KEGG_2021_Human	Insulin resistance	1/108	0.11414221216513072	0.1572898688608827	9.301401869158878	-5.5437021881688855	NFKB1
KEGG_2021_Human	C-type lectin receptor signaling pathway	1/104	0.1101307870056494	0.1572898688608827	9.66747572815534	-5.770076289156004	NFKB1
KEGG_2021_Human	Pathways in cancer	2/531	0.11422240476802195	0.1572898688608827	4.072373751012693	-4.112145636603806	NFKB1;TRAF6
KEGG_2021_Human	TNF signaling pathway	1/112	0.11813755546186366	0.16005733320639592	8.961711711711711	-5.331706526568274	NFKB1
KEGG_2021_Human	Sphingolipid signaling pathway	1/119	0.1250908789190453	0.16678783855872706	8.422669491525424	-4.991352204954326	NFKB1
KEGG_2021_Human	Relaxin signaling pathway	1/129	0.13493965981513528	0.17710830350736506	7.7548828125	-4.562741285776279	NFKB1
KEGG_2021_Human	Ubiquitin mediated proteolysis	1/140	0.14565938613127935	0.1823240877781185	7.131294964028777	-4.155247022438812	TRAF6
KEGG_2021_Human	Autophagy	1/137	0.14274759908195303	0.1823240877781185	7.291360294117647	-4.260528287487475	TRAF6
KEGG_2021_Human	Fluid shear stress and atherosclerosis	1/139	0.1446897687889315	0.1823240877781185	7.183876811594203	-4.189884821040622	NFKB1
KEGG_2021_Human	Apoptosis	1/142	0.14759569010609594	0.1823240877781185	7.028368794326241	-4.0872955859712885	NFKB1
KEGG_2021_Human	Non-alcoholic fatty liver disease	1/155	0.1600868648381378	0.19324914022400952	6.424512987012987	-3.684591600744329	NFKB1
KEGG_2021_Human	Cellular senescence	1/156	0.1610409501866746	0.19324914022400952	6.382258064516129	-3.656151305359152	NFKB1
KEGG_2021_Human	Alcoholism	1/186	0.18921929983322208	0.22386508712662895	5.327027027027027	-2.9347424374485835	HDAC6
KEGG_2021_Human	Transcriptional misregulation in cancer	1/192	0.1947529189002049	0.22409924914544127	5.1557591623036645	-2.815647086064282	NFKB1
KEGG_2021_Human	Chemokine signaling pathway	1/192	0.1947529189002049	0.22409924914544127	5.1557591623036645	-2.815647086064282	NFKB1
KEGG_2021_Human	Diabetic cardiomyopathy	1/203	0.20481075885442057	0.2324878884293423	4.868193069306931	-2.614463741813879	NFKB1
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	1/219	0.21924102109550214	0.24231902331608132	4.501720183486238	-2.3559646623273536	NFKB1
KEGG_2021_Human	cAMP signaling pathway	1/216	0.21655321360035754	0.24231902331608132	4.566279069767442	-2.4016666931883877	NFKB1
KEGG_2021_Human	Human cytomegalovirus infection	1/225	0.22459205877125593	0.24500951865955192	4.377790178571429	-2.268046374240644	NFKB1
KEGG_2021_Human	Ras signaling pathway	1/232	0.23079371515646216	0.2485470778608054	4.241341991341991	-2.1709758732309115	NFKB1
KEGG_2021_Human	Chemical carcinogenesis	1/239	0.2369512430560319	0.2519481571735023	4.112920168067227	-2.0793719054613833	NFKB1
KEGG_2021_Human	Endocytosis	1/252	0.24827051339380346	0.26068403906349363	3.893426294820717	-1.9223154882950422	TRAF6
KEGG_2021_Human	MicroRNAs in cancer	1/310	0.2969745962335009	0.3079736553532602	3.1391585760517797	-1.379772495458499	NFKB1
KEGG_2021_Human	Alzheimer disease	1/369	0.34362041916781694	0.3477604242180316	2.615828804347826	-1.004788438682883	NFKB1
KEGG_2021_Human	Amyotrophic lateral sclerosis	1/364	0.33977695770378774	0.3477604242180316	2.6535812672176307	-1.0316550216467784	HDAC6
KEGG_2021_Human	Pathways of neurodegeneration	1/475	0.4205589366821036	0.4205589366821036	2.0029008438818567	-0.5780753067414636	NFKB1
